Related references
Note: Only part of the references are listed.Connectomics and epilepsy
Jerome Engel et al.
CURRENT OPINION IN NEUROLOGY (2013)
Enzyme induction with antiepileptic drugs: Cause for concern?
Martin J. Brodie et al.
EPILEPSIA (2013)
Antiepileptic drugs and suicidality: An expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Commission on Neuropsychobiology
Marco Mula et al.
EPILEPSIA (2013)
Bumetanide reduces seizure frequency in patients with temporal lobe epilepsy
Sanaz Eftekhari et al.
EPILEPSIA (2013)
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
Tracy Glauser et al.
EPILEPSIA (2013)
Clinical features associated with placebo response in refractory focal epilepsy
Dieter Schmidt et al.
EPILEPSY & BEHAVIOR (2013)
Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats
Ajay K. Srivastava et al.
EPILEPSY RESEARCH (2013)
Progress report on new antiepileptic drugs: A summary of the Eleventh Eilat Conference (EILAT XI)
Meir Bialer et al.
EPILEPSY RESEARCH (2013)
Neuroprotective and antiepileptogenic effects of combination of anti-inflammatory drugs in the immature brain
Young Se Kwon et al.
JOURNAL OF NEUROINFLAMMATION (2013)
KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy
Eugen Trinka et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study
Maria Feldmann et al.
LANCET NEUROLOGY (2013)
Leukocyte trafficking mechanisms in epilepsy
Paolo F. Fabene et al.
MOLECULAR IMMUNOLOGY (2013)
OPINION The placebo response in medicine: minimize, maximize or personalize?
Paul Enck et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Defining epileptogenesis and identifying antiepileptogenic targets in animal models of acquired temporal lobe epilepsy is not as simple as it might seem
Robert S. Sloviter et al.
NEUROPHARMACOLOGY (2013)
Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments
Wolfgang Loescher et al.
NEUROPHARMACOLOGY (2013)
mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy
Emilio Russo et al.
NEUROPHARMACOLOGY (2013)
The role of inflammation in epileptogenesis
Annamaria Vezzani et al.
NEUROPHARMACOLOGY (2013)
The transport of antiepileptic drugs by P-glycoprotein
Chunbo Zhang et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Role of CNS efflux drug transporters in antiepileptic drug delivery: Overcoming CNS efflux drug transport
Heidrun Potschka
ADVANCED DRUG DELIVERY REVIEWS (2012)
Development of biomarkers to chart all Alzheimer's disease stages: The royal road to cutting the therapeutic Gordian Knot
Harald Hampel et al.
ALZHEIMERS & DEMENTIA (2012)
Seizure-Induced Brain-Borne Inflammation Sustains Seizure Recurrence and Blood-Brain Barrier Damage
Laura Librizzi et al.
ANNALS OF NEUROLOGY (2012)
Stiripentol In Severe Myoclonic Epilepsy of Infancy (Dravet Syndrome)
Greg L. Plosker
CNS DRUGS (2012)
Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy
Robin C. C. Ryther et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2012)
Evidence-based review on the natural history of the epilepsies
Dieter Schmidt et al.
CURRENT OPINION IN NEUROLOGY (2012)
P-glycoprotein imaging in temporal lobe epilepsy: In vivo PET experiments with the Pgp substrate [11C]-verapamil
Maria Feldmann et al.
EPILEPSIA (2012)
Long-lasting pro-ictogenic effects induced in vivo by rat brain exposure to serum albumin in the absence of concomitant pathology
Federica Frigerio et al.
EPILEPSIA (2012)
The emerging role of DNA methylation in epileptogenesis
Katja Kobow et al.
EPILEPSIA (2012)
Finding a better drug for epilepsy: Antiepileptogenesis targets
Katja Kobow et al.
EPILEPSIA (2012)
Finding a better drug for epilepsy: Preclinical screening strategies and experimental trial design
Michele Simonato et al.
EPILEPSIA (2012)
Common factors among Alzheimer's disease, Parkinson's disease, and epilepsy: Possible role of the noradrenergic nervous system
Patricia Szot
EPILEPSIA (2012)
Systems biology impact on antiepileptic drug discovery
Doru Georg Margineanu
EPILEPSY RESEARCH (2012)
Lamotrigine (Lamictal IR) for the treatment of bipolar disorder
Charles L. Bowden et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Blood-brain barrier dysfunction, TGFβ signaling, and astrocyte dysfunction in epilepsy
Uwe Heinemann et al.
GLIA (2012)
Can neurobiological pathogenic mechanisms of depression facilitate the development of seizure disorders?
Andres M. Kanner
LANCET NEUROLOGY (2012)
Clinical trials for therapeutic assessment of antiepileptic drugs in the 21st century: obstacles and solutions
Daniel Friedman et al.
LANCET NEUROLOGY (2012)
Finding the epileptogenesis switch
Annamaria Vezzani
NATURE MEDICINE (2012)
GABAergic excitation after febrile seizures induces ectopic granule cells and adult epilepsy
Ryuta Koyama et al.
NATURE MEDICINE (2012)
Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects
Eva M. Jimenez-Mateos et al.
NATURE MEDICINE (2012)
Perampanel-new promise for refractory epilepsy?
Wolfgang Loescher et al.
NATURE REVIEWS NEUROLOGY (2012)
Pharmacoresistance and the role of surgery in difficult to treat epilepsy
Samuel Wiebe et al.
NATURE REVIEWS NEUROLOGY (2012)
Dopamine abnormalities in the neocortex of patients with temporal lobe epilepsy
Luisa Rocha et al.
NEUROBIOLOGY OF DISEASE (2012)
Evidence-based guideline update: Medical treatment of infantile spasms Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
C. Y. Go et al.
NEUROLOGY (2012)
Patterns of treatment response in newly diagnosed epilepsy
M. J. Brodie et al.
NEUROLOGY (2012)
Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway
Robert H. Scannevin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Neuron-Restrictive Silencer Factor-Mediated Hyperpolarization-Activated Cyclic Nucleotide Gated Channelopathy in Experimental Temporal Lobe Epilepsy
Shawn McClelland et al.
ANNALS OF NEUROLOGY (2011)
Biomarkers in epilepsy: introduction
Jerome Engel
BIOMARKERS IN MEDICINE (2011)
IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures
Annamaria Vezzani et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
The Pharmacology of New Antiepileptic Drugs
Emilio Perucca
CNS DRUGS (2011)
Do ATP-Binding Cassette Transporters Cause Pharmacoresistance in Epilepsy? Problems and Approaches in Determining which Antiepileptic Drugs are Affected
Wolfgang Loescher et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures
Jonathan J. Halford et al.
EPILEPSIA (2011)
Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma
Wolfgang Loescher et al.
EPILEPSIA (2011)
Antiepileptic drug discovery: Does mechanism of action matter?
Dieter Schmidt
EPILEPSY & BEHAVIOR (2011)
Antiepileptic drug therapy: Does mechanism of action matter?
Martin Brodie et al.
EPILEPSY & BEHAVIOR (2011)
Antiepileptic and Antiepileptogenic Performance of Carisbamate after Head Injury in the Rat: Blind and Randomized Studies
Clifford L. Eastman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials
Philippe Ryvlin et al.
LANCET NEUROLOGY (2011)
Mechanisms of epileptogenesis and potential treatment targets
Asla Pitkanen et al.
LANCET NEUROLOGY (2011)
NETWORKING FOR NEW DRUGS
Claire Ainsworth
NATURE MEDICINE (2011)
The role of inflammation in epilepsy
Annamaria Vezzani et al.
NATURE REVIEWS NEUROLOGY (2011)
Progress on the issue of excitotoxic injury modification vs. real neuroprotection; implications for post-traumatic epilepsy
Robert S. Sloviter
NEUROPHARMACOLOGY (2011)
Identifying targets for preventing epilepsy using systems biology
Jeffrey A. Loeb
NEUROSCIENCE LETTERS (2011)
Human clinical trails in antiepileptogenesis
Ram Mani et al.
NEUROSCIENCE LETTERS (2011)
Interleukin-1β Biosynthesis Inhibition Reduces Acute Seizures and Drug Resistant Chronic Epileptic Activity in Mice
Mattia Maroso et al.
NEUROTHERAPEUTICS (2011)
A Systems Level, Functional Genomics Analysis of Chronic Epilepsy
Kellen D. Winden et al.
PLOS ONE (2011)
Basic mechanisms of antiepileptic drugs and their pharmacokinetic/pharmacodynamic interactions: an update
Wladyslaw Lason et al.
PHARMACOLOGICAL REPORTS (2011)
Combining antiepileptic drugs-Rational polytherapy?
Martin J. Brodie et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2011)
Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs
Wolfgang Loescher
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2011)
Leveraging Biomarker Platforms and Systems Biology for Rehabilomics and Biologics Effectiveness Research
Firas H. Kobeissy et al.
PM&R (2011)
Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report
Stefano Sotgiu et al.
BMC NEUROLOGY (2010)
Imaging of P-glycoprotein Function and Expression to Elucidate Mechanisms of Pharmacoresistance in Epilepsy
Wolfgang Loescher et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy
Emilio Russo et al.
EPILEPSIA (2010)
Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
Patrick Kwan et al.
EPILEPSIA (2010)
Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: Systematic review and meta-analysis
Stefan Beyenburg et al.
EPILEPSIA (2010)
Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009
Anne T. Berg et al.
EPILEPSIA (2010)
A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures
Michel Baulac et al.
EPILEPSY RESEARCH (2010)
Progress report on new antiepileptic drugs: A summary of the Tenth Eilat Conference (EILAT X)
Meir Bialer et al.
EPILEPSY RESEARCH (2010)
Increased Risk of Death Among Children With Lennox-Gastaut Syndrome and Infantile Spasms
Andrew R. Autry et al.
JOURNAL OF CHILD NEUROLOGY (2010)
Disease-Modifying Effects of Phenobarbital and the NKCC1 Inhibitor Bumetanide in the Pilocarpine Model of Temporal Lobe Epilepsy
Claudia Brandt et al.
JOURNAL OF NEUROSCIENCE (2010)
Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures
Mattia Maroso et al.
NATURE MEDICINE (2010)
Key factors in the discovery and development of new antiepileptic drugs
Meir Bialer et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury
Dan Shlosberg et al.
NATURE REVIEWS NEUROLOGY (2010)
Prevention or Modification of Epileptogenesis after Brain Insults: Experimental Approaches and Translational Research
Wolfgang Loescher et al.
PHARMACOLOGICAL REVIEWS (2010)
Benefit of combination therapy in epilepsy: A review of the preclinical evidence with levetiracetam
Rafal M. Kaminski et al.
EPILEPSIA (2009)
High-frequency oscillations: What is normal and what is not?
Jerome Engel et al.
EPILEPSIA (2009)
Preventing and treating posttraumatic seizures: The human experience
Nancy R. Temkin
EPILEPSIA (2009)
Drug treatment of epilepsy: Options and limitations
Dieter Schmidt
EPILEPSY & BEHAVIOR (2009)
Blood-brain barrier breakdown-inducing astrocytic transformation: Novel targets for the prevention of epilepsy
Alon Friedman et al.
EPILEPSY RESEARCH (2009)
Pharmacodynamic interactions between antiepileptic drugs: preclinical data based on isobolography
Stanislaw J. Czuczwar et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Transcriptome Profiling Reveals TGF-β Signaling Involvement in Epileptogenesis
Luisa P. Cacheaux et al.
JOURNAL OF NEUROSCIENCE (2009)
Lessons from 60 years of pharmaceutical innovation
Bernard Munos
NATURE REVIEWS DRUG DISCOVERY (2009)
NEW DEVELOPMENTS IN ANTIEPILEPTIC DRUG RESISTANCE: AN INTEGRATIVE VIEW
Dieter Schmidt et al.
EPILEPSY CURRENTS (2009)
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
Ling-Hui Zeng et al.
ANNALS OF NEUROLOGY (2008)
The role of cytokines in the pathophysiology of epilepsy
Annamaria Vezzani et al.
BRAIN BEHAVIOR AND IMMUNITY (2008)
The state of innovation in drug development
I. Kola
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Early treatment suppresses the development of spike-wave epilepsy in a rat model
Hal Blumenfeld et al.
EPILEPSIA (2008)
Reduction of secondarily generalized tonic-clonic (SGTC) seizures with pregabalin
Deborah E. Briggs et al.
EPILEPSY RESEARCH (2008)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
A role for leukocyte-endothelial adhesion mechanisms in epilepsy
Paolo F. Fabene et al.
NATURE MEDICINE (2008)
Quantifying the response to antiepileptic drugs
Yitzhak Schiller et al.
NEUROLOGY (2008)
Levetiracetam: the first SV2A ligand for the treatment of epilepsy
Henrik Klitgaard et al.
EXPERT OPINION ON DRUG DISCOVERY (2007)
The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial
Anthony G. Marson et al.
LANCET (2007)
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial
Anthony G. Marson et al.
LANCET (2007)
Development of new antiepileptic drugs: challenges, incentives, and recent advances
Emilio Perucca et al.
LANCET NEUROLOGY (2007)
The multidrug transporter hypothesis of drug resistance in epilepsy:: Proof-of-principle in a rat model of temporal lobe epilepsy
Claudia Brandt et al.
NEUROBIOLOGY OF DISEASE (2006)
Neuronal sensitivity to kainic acid is dependent on the Nrf2-mediated actions of the antioxidant response element
Andrew D. Kraft et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Natural history of treated childhood-onset epilepsy:: prospective, long-term population-based study
M Sillanpää et al.
BRAIN (2006)
Clinical trials for prevention of epileptogenesis
ST Herman
EPILEPSY RESEARCH (2006)
Molecular and cellular mechanisms of pharmacoresistance in epilepsy
S Remy et al.
BRAIN (2006)
NKCC1 transporter facilitates seizures in the developing brain
VI Dzhala et al.
NATURE MEDICINE (2005)
An integrative genomics approach to infer causal associations between gene expression and disease
EE Schadt et al.
NATURE GENETICS (2005)
Drug resistance in epilepsy:: Putative neurobiologic and clinical mechanisms
D Schmidt et al.
EPILEPSIA (2005)
Multiple facets of GABAergic neurons and synapses: multiple fates of GABA signalling in epilepsies
R Cossart et al.
TRENDS IN NEUROSCIENCES (2005)
Adverse effects of antiepileptic drugs
E Perucca et al.
ACTA NEUROLOGICA SCANDINAVICA (2005)
Dysregulation of the TSC-mTOR pathway in human disease
K Inoki et al.
NATURE GENETICS (2005)
Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus
C Brandt et al.
EPILEPSIA (2004)
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
MA Rogawski et al.
NATURE MEDICINE (2004)
The neurobiology of antiepileptic drugs
MA Rogawski et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy
MD Privitera et al.
ACTA NEUROLOGICA SCANDINAVICA (2003)
On the origin of interictal activity in human temporal lobe epilepsy in vitro
I Cohen et al.
SCIENCE (2002)
Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs
B Meldrum
EPILEPSY RESEARCH (2002)
Use of epileptic animals for adverse effect testing
H Klitgaard et al.
EPILEPSY RESEARCH (2002)
Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis
A Vezzani et al.
EPILEPSIA (2002)
Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy
ME Barton et al.
EPILEPSY RESEARCH (2001)
Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice
A Vezzani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
